Sei Investments Co. Raises Position in Thermo Fisher Scientific Inc (TMO)
Sei Investments Co. boosted its holdings in Thermo Fisher Scientific Inc (NYSE:TMO) by 12.2% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 261,919 shares of the medical research company’s stock after buying an additional 28,541 shares during the quarter. Sei Investments Co. owned approximately 0.07% of Thermo Fisher Scientific worth $49,556,000 at the end of the most recent reporting period.
Other institutional investors have also recently added to or reduced their stakes in the company. Proficio Capital Partners LLC grew its position in shares of Thermo Fisher Scientific by 71.5% during the 1st quarter. Proficio Capital Partners LLC now owns 607 shares of the medical research company’s stock worth $105,000 after buying an additional 253 shares during the period. Chicago Partners Investment Group LLC acquired a new stake in shares of Thermo Fisher Scientific during the 2nd quarter worth approximately $108,000. Shine Investment Advisory Services Inc. acquired a new stake in shares of Thermo Fisher Scientific during the 2nd quarter worth approximately $113,000. Ropes Wealth Advisors LLC grew its position in shares of Thermo Fisher Scientific by 15.8% during the 2nd quarter. Ropes Wealth Advisors LLC now owns 710 shares of the medical research company’s stock worth $124,000 after buying an additional 97 shares during the period. Finally, Atlantic Trust LLC acquired a new stake in shares of Thermo Fisher Scientific during the 2nd quarter worth approximately $138,000. Hedge funds and other institutional investors own 86.18% of the company’s stock.
Several analysts recently issued reports on the stock. Zacks Investment Research raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $215.00 price target for the company in a research report on Tuesday, October 31st. Leerink Swann reissued a “buy” rating on shares of Thermo Fisher Scientific in a research report on Monday, October 30th. Deutsche Bank set a $226.00 price target on shares of Thermo Fisher Scientific and gave the company a “buy” rating in a research report on Thursday, October 26th. Jefferies Group reissued a “hold” rating and issued a $195.00 price target on shares of Thermo Fisher Scientific in a research report on Thursday, September 28th. Finally, Goldman Sachs Group assumed coverage on shares of Thermo Fisher Scientific in a research report on Tuesday, September 26th. They issued a “buy” rating and a $225.00 price target for the company. One equities research analyst has rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. Thermo Fisher Scientific currently has an average rating of “Buy” and a consensus target price of $205.71.
Shares of Thermo Fisher Scientific Inc (NYSE TMO) traded down $0.56 during trading on Friday, reaching $192.20. The company had a trading volume of 1,335,426 shares, compared to its average volume of 1,336,481. Thermo Fisher Scientific Inc has a fifty-two week low of $139.32 and a fifty-two week high of $201.20. The company has a market cap of $77,297.88, a PE ratio of 21.18, a P/E/G ratio of 1.76 and a beta of 1.07. The company has a quick ratio of 0.81, a current ratio of 1.26 and a debt-to-equity ratio of 0.85.
Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings data on Wednesday, October 25th. The medical research company reported $2.31 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.24 by $0.07. The business had revenue of $5.12 billion for the quarter, compared to analysts’ expectations of $5.03 billion. Thermo Fisher Scientific had a return on equity of 15.94% and a net margin of 11.73%. The firm’s quarterly revenue was up 13.9% compared to the same quarter last year. During the same period in the previous year, the business posted $2.03 EPS. research analysts predict that Thermo Fisher Scientific Inc will post 9.36 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Monday, January 15th. Shareholders of record on Friday, December 15th will be issued a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 0.31%. The ex-dividend date is Thursday, December 14th. Thermo Fisher Scientific’s payout ratio is presently 10.19%.
In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 50,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 15th. The stock was sold at an average price of $188.39, for a total value of $9,419,500.00. Following the completion of the sale, the chief executive officer now owns 252,577 shares of the company’s stock, valued at $47,582,981.03. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, VP Peter E. Hornstra sold 3,894 shares of the company’s stock in a transaction that occurred on Tuesday, September 5th. The stock was sold at an average price of $185.18, for a total value of $721,090.92. Following the completion of the sale, the vice president now directly owns 19,751 shares of the company’s stock, valued at approximately $3,657,490.18. The disclosure for this sale can be found here. 0.49% of the stock is owned by insiders.
ILLEGAL ACTIVITY WARNING: This article was posted by Daily Political and is owned by of Daily Political. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright law. The correct version of this article can be viewed at https://www.dailypolitical.com/2017/12/02/sei-investments-co-raises-position-in-thermo-fisher-scientific-inc-tmo.html.
Thermo Fisher Scientific Company Profile
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.